This Monday, May 15th, representatives from bioXclusters plus and Fenglin Group signed a Gateway Agreement to offer free services and guidance for SMEs in their operations in China. Services will include assistance in market access, private investment, clinical trials and soft landing packages. Continue reading
On 15th – 16th May bioXclusters plus will carry out a China Mission, bringing clusters and companies together at the Sino European Bio Partnering (SEBP) event at a reduced rate. Following bioXclusters plus strategy, the metacluster alliance will sign an MoU with Fenglin Group in order to provide guidance, consultancy and support to European life -sciences SMEs interested in doing business in China. Continue reading
The bioXclusters plus alliance is pleased to announce that in November 2016, it signed a new, two-year cooperation agreement with the Chuncheon Bioindustry Foundation (CBF) from South Korea. CBF is a government funded organisation, which contributes to the improvement of local and national bioindustries.
CBF provides several systematic supports for biotech business. It represents member companies and research organisations located in the Gangwon Province of South Korea which work in the fields of biotechnology, pharmacy and medical science .
For more information about CBF, please visit the CBF website by clicking here.
Thanks to an exceptional and mutual collaboration between bioXclusters plus and the EU-Japan Centre, around 60 participants from nine different European countries (Austria, France, Germany, Greece, Italy, Netherlands, Spain, Sweden and UK) participated in the joint mission to Osaka and Yokohama which took place from 10th to 14th October 2016. Continue reading
The European Strategic Cluster Partnership on Personalised Healthcare, bioXclusters plus – which has joined together four leading European biotech clusters, Biocat (Catalonia), BioM (Bavaria), BioPmed (Piedmont) and Lyonbiopole (Auvergne Rhone-Alpes) – has organised a mission to Japan which will take place from 10th to 14th October 2016. This mission, which will visit Osaka and Yokohama, has been organised in collaboration with the EU Japan Centre.
The visiting delegation will be composed of representatives from the four metacluster partners and 26 SMEs from their respective regions:
2bind GmbH, 4SC AG, Ability Pharmaceuticals S.L., Apceth GmbH & Co. KG, Ascenion GmbH, Bioindustry Park Silvano Fumero SpA, Boeters &LieckCoriolis Pharma Research GmbH, CTIBiotech, CYTOO SA, FGK Clinical Research GmbH, Gams Wellness, genOway, Indicia Production, Iris Biotech GmbH, Klifovet AG, Laboratorios Rubió S.A, Laboratorios Salvat S.A., Leukocare AG, Leukos Biotech, Medigene AG, Mind the Byte S.L., Novotec, Theranexus, Thrombotargets Europe S.L., Zeclinics S.L. Continue reading
The European Strategic Cluster Partnership alliance on Personalised Healthcare, bioXclusters plus, which joins together four leading European Bio Clusters – Biocat, BioM, BioPmed and Lyonbiopole – is pleased to invite European SMEs based in its regions to join its mission to Japan. This mission has been organised in the framework of BioJapan (Oct. 12 to 14, 2016). Continue reading
The European meta-cluster project bioXclusters plus (European Strategic Cluster Partnership on Personalised Healthcare) has been selected by the European Commission Executive Agency for Small and Medium-sized Entreprises (EASME) for the call for proposals COS-CLUSTER-2014-3-03 – Cluster Going International. Continue reading